(Q24628874)

1

0 references

S A Gallagher

2

0 references

A Mascola

3

0 references

R M Moloney

4

0 references

R S Stafford

Pharmacoepidemiology and Drug Safety

5

0 references

language of work or name

English

0 references

publication date

February 2011

0 references

published in

0 references

volume

20

0 references

issue

2

0 references

page(s)

177-84

0 references

cites work

The underutilization of cardiac medications of proven benefit, 1990 to 2002

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069498

National trends in the outpatient diagnosis and treatment of bipolar disorder in youth

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069498

Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069498

Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069498

Atypical antipsychotic drugs and the risk of sudden cardiac death

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069498

First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069498

Who are the new users of antipsychotic medications?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069498

Antipsychotic drug use and mortality in older adults with dementia

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069498

Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment

27 September 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069498

27 September 2017

https://api.crossref.org/works/10.1002%2FPDS.2082

The quality of antipsychotic drug prescribing in nursing homes

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069498

Concordance of severity ratings provided in four drug interaction compendia

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069498

Are drugs within a class interchangeable?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069498

Prescription drugs and the changing patterns of treatment for mental disorders, 1996-2001.

27 September 2017

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FPDS.2082

Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FPDS.2082

21 January 2018

Identifiers

DOI

10.1002/PDS.2082

1 reference

1 reference

1 reference

PubMed publication ID

21254289

1 reference